The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author Title [ Type(Desc)] Year
Journal Article
Athyros, V. G., Katsiki N., & Karagiannis A. (2013).  Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.. Angiology. 64(8), 572-5.
Tziomalos, K., Athyros V. G., Paschos P., & Karagiannis A. (2015).  Nonalcoholic fatty liver disease and statins.. Metabolism. 64(10), 1215-23.
Muzurović, E., Polyzos S., Mikhailidis D., Borozan S., Novosel D., Cmiljanić O., et al. (2022).  Non-alcoholic fatty liver disease in children.. Curr Vasc Pharmacol.
Polyzos, S. A., Mousiolis A., Mintziori G., & Goulis D. G. (2020).  Nonalcoholic fatty liver disease in males with low testosterone concentrations.. Diabetes Metab Syndr. 14(5), 1571-1577.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2012).  Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.. Curr Vasc Pharmacol. 10(2), 162-72.
Polyzos, S. A., Goulis D. G., Kountouras J., Mintziori G., Chatzis P., Papadakis E., et al. (2014).  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.. Hormones (Athens). 13(4), 519-31.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Macut, D., Tziomalos K., Božić-Antić I., Bjekić-Macut J., Katsikis I., Papadakis E., et al. (2016).  Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.. Hum Reprod. 31(6), 1347-53.
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Vachliotis, I., Goulas A., Papaioannidou P., & Polyzos S. A. (2021).  Nonalcoholic fatty liver disease: lifestyle and quality of life.. Hormones (Athens).
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2012).  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.. J Clin Gastroenterol. 46(4), 272-84.
Polyzos, S. A., Papaefthymiou A., Doulberis M., & Kountouras J. (2023).  Nonalcoholic fatty liver disease test: an external validation cohort.. Hormones (Athens).
Polyzos, S. A., Kountouras J., & Zavos C. (2009).  Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines.. Curr Mol Med. 9(3), 299-314.
Pafili, K., Paschou S. A., Armeni E., Polyzos S. A., Goulis D. G., & Lambrinoudaki I. (2022).  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.. J Endocrinol Invest.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Emeriewen, K., Kadare S., Tsatsos M., Athanasiadis Y., MacGregor C., & Rassam S. (2016).  Non-arteritic Anterior Ischaemic Optic Neuropathy after Uneventful Cataract Extraction.. Neuroophthalmology. 40(5), 225-228.
Dotis, J., Pana Z. Dorothea, & Roilides E. (2013).  Non-Aspergillus fungal infections in chronic granulomatous disease.. Mycoses. 56(4), 449-62.
Fountoulakis, K. N., Balaris D., Nikolaou V., & Νimatoudis J. (2016).  [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].. Psychiatriki. 27(4), 253-263.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Kouidou, S., Agidou T., Kyrkou A., Andreou A., Katopodi T., Georgiou E., et al. (2005).  Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.. Lung Cancer. 50(3), 299-307.
Konstantinou, D. M., Chatzizisis Y. S., Louridas G. E., Parcharidis G. E., & Giannoglou G. D. (2010).  Non-diabetic hyperglycaemia correlates with angiographic coronary artery disease prevalence and severity.. Diabetes Metab. 36(5), 402-8.
Nikolaidou, B., Anyfanti P., Gavriilaki E., Lazaridis A., Triantafyllou A., Zarifis H., et al. (2022).  Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.. J Hum Hypertens. 36(9), 805-810.
Sarigianni, M., Dimitrakopoulos K., & Tsapas A. (2014).  Non-dipping status in arterial hypertension: an overview.. Curr Vasc Pharmacol. 12(3), 527-36.
Perivoliotis, K., Spyridakis M., Zintzaras E., Arnaoutoglou E., Pramateftakis M-G., & Tepetes K. (2020).  Non-Doppler hemorrhoidal artery ligation and hemorrhoidopexy combined with pudendal nerve block for the treatment of hemorrhoidal disease: a non-inferiority randomized controlled trial.. Int J Colorectal Dis.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.